Amsphere A3
A next generation, high capacity protein A chromatography resin for advanced protein separation in downstream processing.
Using Innovation to De-Risk &
Accelerate the Discovery &
Development of New Therapeutics
Introducing
CELLiST™ BASAL CHO MX
A Breakthrough in Cell Culture Media
BASAL CHO MX growth medium provides a well-balanced combination of amino acids and essential nutrients, ensuring robust cell growth and maximum productivity in biologics manufacturing.
CELLiST™ serves as a comprehensive solution for all your biologics manufacturing needs.
Want to Accelerate Your Novel Therapies or Innovative Technologies?
Get more information about our JSR Life Sciences Venture Fund
Amsphere™ A3
A NextGen Protein A Chromatography Resin
Amsphere A3 is a next generation Protein A chromatography resin for advanced protein separation in downstream processing of therapeutic antibodies manufacturing.
Besides an outstanding high capacity, Amsphere A3 has an overall improved process robustness, flow characteristics, optimized impurity removal, productivity and resin lifetime.
ChromNeX
An innovative chromatography platform that helps improve the operational efficiency & productivity of your purification processes.
Magnosphere
Standardized hydrophilic & hydrophobic magnetic microparticles used for life science applications.
Blockmaster
Blocking agent composed of 100% chemically synthesized polymers, devoid of the safety & purity issues of biological blocking reagents.
IMMUTEX
Uniform-sized polystyrene latex particles for agglutination tests with a variety of sizes & surfaces available.
MBL
Biomarker discovery for companion
diagnostics and the development
& manufacturing of IVDs.
Contract Research
Crown Bioscience is a contract research & translational technology company making precision medicine a reality.
.png?width=339&height=90&name=similisbio_logo_color_med%20(2).png){kind=logo}
Biosimilar Development
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.
Contract Manufacturing
KBI Biopharma is a contract development and manufacturing organization for the 21st Century.
Speaker: Atul D. Joshi Ph.D., Principal Scientist - Upstream Process Development
OnDemand Webinar
CELLiST BASAL CHO MX: High-Productivity Cell Culture Medium for CHO Cell Bioproduction
We are excited to have a speaker from our affiliate company, KBI Biopharma, a global CDMO, present on the new high-productivity cell culture medium.
In recent years, better understanding of CHO cell metabolism has resulted in rapid improvements of cell culture medium formulation resulting in better cell culture performance.
This presentation will focus on the development and performance of the newly launched CELLiST BASAL CHO MX medium. Scientists from KBI Biopharma and JSR Life Sciences have leveraged their process development expertise to develop a unique cell culture medium formulation which has demonstrated better cell culture performance and higher productivity.
MBL Can Help
MBL in Japan is a one stop shop. MBL is #1 for new IVD medical reimbursement approvals in Japan with an Extensive KOL Network required for approvals.
